For a breast cancer patients, anything that makes treatment and recovery a little easier is a dream come true. That's why patients like Brenda Mijares, a breast cancer survivor who benefitted from BlossomTM, Marz Medical's technology, that is intended to shorten...
CyberHeart, a startup that is developing the first non-invasive robotic ablation treatment for cardiac arrhythmias, has recently signed an agreement with the National Cancer Center (NCC) in Tokyo to install the CyberHeart system. This makes NCC the world's...
EchoPixel, a startup that has developed True 3D, a medical visualization software platform, is undoubtedly one of the favorite stops when touring the Fogarty Institute. Using 3D glasses and a special display, physicians now have the opportunity to view and interact...
Silicon Valley and the greater San Francisco Bay Area have long enjoyed a reputation and foothold as the epicenter of innovation, home to many of the world's most impressive startup launches and accounting for as much as 43% of venture capital funding. But while...
InPress Technologies and nVision, two Fogarty Institute companies aiming to improve women's health, recently received Series A and Series B rounds of funding respectively, further validating the legitimacy and significance of the medical devices they are developing....
Over the past three decades, skin cancer has become the most prevalent types of cancer, outpacing all other types of cancer combined, including of the breast, lung and prostate. Each year, more than 5.4 million skin tumors are treated in the U.S. alone, with nearly $5...
It's been a busy and exciting time at G-Tech Medical, a Fogarty Institute company that records the electrical signals that naturally occur in the digestive tract (also called the gastrointestinal or GI tract) and is studying the patterns of stomach and intestinal...
Since joining the Fogarty Institute less than a year ago with its U.S. FDA 510(k) clearance in hand, Marz Medical has received two patents and identified a novel plan to raise money and develop its product. The startup, which is developing a technology intended to...
Cardiac arrhythmia is much too common, affecting 2.5 million Americans and costing $6.5 billion in healthcare costs annually. Current therapies, including medicines and catheter ablation, are effective for only a small percentage of patients. If left untreated,...
Founded by Dr. Pete Coelho and led by Peter David, MedicalCue has developed a bedside tablet computer system that guides medical teams during newborn resuscitation. Much like a GPS offering real-time traffic avoidance, the startup's technology provides dynamic,...